These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Complete androgen deprivation prior to radical prostatectomy in patients with stage T3 cancer of the prostate. Flamm J; Fischer M; Höltl W; Pflüger H; Tomschi W Eur Urol; 1991; 19(3):192-5. PubMed ID: 1830275 [TBL] [Abstract][Full Text] [Related]
7. Case report: lymphangitic carcinomatosis from cervical carcinoma--an unusual presentation of diffuse interstitial lung disease. Perez-Lasala G; Cannon DT; Mansel JK; McGehee RP; Allen KG Am J Med Sci; 1992 Mar; 303(3):174-6. PubMed ID: 1595780 [TBL] [Abstract][Full Text] [Related]
8. A multicenter trial comparing the luteinizing hormone releasing hormone analog Zoladex, with Zoladex plus flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group. Lunglmayr G Eur Urol; 1990; 18 Suppl 3():28-9. PubMed ID: 2151273 [No Abstract] [Full Text] [Related]
9. Pulmonary lymphangitic carcinomatosis as a primary manifestation of gastric carcinoma in a young adult: a case report and review of the literature. Moubax K; Wuyts W; Vandecaveye V; Prenen H BMC Res Notes; 2012 Nov; 5():638. PubMed ID: 23158653 [TBL] [Abstract][Full Text] [Related]
10. [Lack of effect of therapy with LHRH analogs, alone or associated with flutamide, on prolactin levels in advanced prostatic carcinoma]. Banchini A; Zavaroni D; Tarditi E; Cortellini P; Ziveri M; Polotti R; Stefani F; Valenti G Minerva Endocrinol; 1989; 14(3):165-8. PubMed ID: 2533662 [TBL] [Abstract][Full Text] [Related]
11. FDG PET/CT in assessment of pulmonary lymphangitic carcinomatosis. Prakash P; Kalra MK; Sharma A; Shepard JA; Digumarthy SR AJR Am J Roentgenol; 2010 Jan; 194(1):231-6. PubMed ID: 20028927 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis of lymphangitic carcinomatosis by transbronchial lung biopsy. Torrington KG; Hooper RG South Med J; 1978 Dec; 71(12):1487-8. PubMed ID: 725626 [TBL] [Abstract][Full Text] [Related]
16. LHRH-analogues therapy for metastatic prostate cancer. Debruyne FM; Fernandez del Moral P; Geboers AD Prog Clin Biol Res; 1988; 260():27-39. PubMed ID: 2966406 [No Abstract] [Full Text] [Related]
17. LHRH analogues in combination with an anti-androgen in the treatment of advanced disease. Denis L Horm Res; 1989; 32 Suppl 1():66-7; discussion 68. PubMed ID: 2533158 [TBL] [Abstract][Full Text] [Related]
18. Clinical study of an LH-RH agonist (ICI 118.630, Zoladex) in the treatment of prostatic cancer. Mauriac L; Coste P; Richaud P; Lamarche P; Mage P; Bonichon F Am J Clin Oncol; 1988; 11 Suppl 2():S117-9. PubMed ID: 2977265 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary metastases in metastatic prostate cancer: host tissue-tumor cell interactions and response to hormone therapy. Behrakis P; Koutsilieris M Anticancer Res; 1997; 17(3A):1517-8. PubMed ID: 9179189 [TBL] [Abstract][Full Text] [Related]
20. Zoladex and flutamide vs orchidectomy: a phase III EORTC 30853 trial. EORTC Urological Group. Carvalho AP; de Moura JL; Denis L; Newling D; Smith P; Bono A; Sylvester R; De Pauw M; Ongena P Prog Clin Biol Res; 1989; 303():129-43. PubMed ID: 2528736 [No Abstract] [Full Text] [Related] [Next] [New Search]